Episode 6: Interview with Ann Jordan, CEO of ASQ

January 24, 2023

Host Jim Fries speaks to Ann Jordan, CEO of ASQ in the sixth episode of The Patient Safety Podcast about recent changes in quality management since the COVID-19 pandemic. Ann discusses how these quality changes […]

Rx-360 Insights

Rx-360 Continues Growth with Key Leadership Appointments

December 1, 2022

Philadelphia, December 1, 2022 — Rx-360, an international pharmaceutical supply chain consortium, is proud to announce that it has hired Ben Mills as Senior Director of Operations, Joint Audit Program/Quality, and Kristen Farr as Senior […]


Rx-360 Best Practices Quality Agreement Guide

November 17, 2022

This Best Practices Quality Agreement Guide is intended to assist both Customers and Suppliers in efficiently managing the initiation, negotiation, implementation, and ongoing maintenance of quality agreements. “Supplier” is used broadly in this document to […]

Rx-360 Insights

10+ Year Rx-360 Member Reaches Audit Milestone

July 25, 2022

  The Rx-360 Credit Program is a members-only benefit that GSK has found to be tremendously valuable, as it has generated nearly $100,000 in credits for the science-led global healthcare company. “Not only does Rx-360 […]


Episode 5: Interview with Best-Selling Author Katherine Eban

July 14, 2022

Host Jim Fries speaks to Katherine Eban, contributing editor for Vanity Fair and a New York Times best-selling author, in the fifth episode of The Patient Safety Podcast. Eban walks Fries through her investigation into […]


Episode 4: Interview with Leigh Verbois, Director of the Office of Drug Security, Integrity and Response for the FDA

June 7, 2022

Host Jim Fries speaks to Leigh Verbois, the Director of the Office of Drug Security, Integrity, and Response for the FDA, in the fourth episode of The Patient Safety Podcast. The episode covers Verbois’ time […]


Human Blood Origin Materials for Cell & Gene Therapy Manufacturing Supplier Questionnaire

May 24, 2022

Materials derived from human blood such as human serum albumin and transferrin are frequently used either as components of cell culture medium or in other processes. Suppliers of such reagents have incorporated multiple mitigation steps such as sourcing pharmaceutical grade or licensed drug product, sourcing from safe geographical regions, testing for contaminants and inactivation. In addition, this information needs to be available for review during inspections and in regulatory filings. This questionnaire is a comprehensive list of those requirements and will be a useful document for reference.

Rx-360 Insights

Rx-360 Patient Safety Podcast: Interview with USP CEO Ron Piervincenzi, Ph.D.

April 12, 2022

Rx-360 released the third episode of The Patient Safety Podcast, featuring Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP).